Voi kiinnostaa metformiinia käyttäviä

Leikin AI:lla (tuloksen suurin piirtein tiesinkin) :
'AI Mode conversationYou said: metformin mortality benefitmetformin mortality benefit +8 In patients with type 2 diabetes, metformin is consistently associated with reduced all-cause mortality and fewer cardiovascular events. Observational studies suggest that this benefit may even extend to non-diabetic populations, though definitive proof from large-scale randomized trials targeting longevity in healthy individuals is still pending.The mortality benefits of metformin are supported by several key findings:All-Cause Mortality: Systematic reviews show that diabetic patients taking metformin have a significantly lower risk of death compared to both matched diabetics on other medications and, in some studies, non-diabetic individuals.Cardiovascular Protection: Metformin lowers the risk of major adverse cardiovascular events (MACEs), such as heart attacks and strokes, through improvements in insulin sensitivity and lipid profiles.Anti-Aging Research: Preclinical data and observational studies indicate metformin may reduce the incidence of age-related conditions, including certain cancers and cognitive decline. This has sparked major initiatives like the TAME (Targeting Aging with Metformin) Trial, which aims to definitively evaluate its anti-aging properties.Despite these promising findings from observational and retrospective studies, randomized controlled trials in non-diabetic populations have not yet confirmed a universal extension of lifespan.Would you like to explore:Metformin's impact on cancer risk reduction?How it compares to newer diabetes medications for heart health?The specific mechanisms believed to slow aging?Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis - PubMed15 Nov 2017 — The review found that metformin may reduce all-cause mortality and diseases of aging independently of its effect on diabetes control. The review's authors concl...National Institutes of Health (NIH) | (.gov)Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials - PubMed10 Mar 2021 — An updated meta-analysis of randomized controlled trials (RCTs) found that metformin is associated with a lower risk of major adverse cardiovascular events (MAC...National Institutes of Health (NIH) | (.gov)Metformin and all-cause mortality in older adults with type 2 diabetes ...Abstract. Background: Metformin reduces mortality in type 2 diabetes mellitus (T2DM), but its underlying pathways remain incompletely understood. We hypothesize...ScienceDirect.comEffect of Metformin and Lifestyle Interventions on Mortality in the ...25 Oct 2021 — Over a median of 21 years (interquartile range 20–21), 453 participants died. Cancer was the leading cause of death (n = 170), followed by cardiovascular diseas...diabetesjournals.orgMETFORMIN AND ITS EFFECT ON CARDIOVASCULAR OUTCOMES AND MORTALITY IN DIABETES | Journal of Population Therapeutics and Clinical Pharmacology23 Sept 2024 — Metformin is a widely prescribed medication for type 2 diabetes mellitus (T2DM). It has been shown to have cardiovascular benefits, including: * **Reduced major...Journal of Population Therapeutics and Clinical Pharmacology4mThe TAME Trial: Targeting Aging with MetforminNutritionFacts.org·NutritionFacts.org1:05Could Metformin be an anti-aging wonder drug?YouTube·YOGABODY1mMetformin, the Big New "Anti-Aging" Drug, ExplainedYouTube·Cleo AbramThe Benefits of Metformin for Type 2 Diabetes, and Potential Uses ...15 Dec 2025 — The Takeaway * Metformin is a widely available, affordable, and safe first-line medication for type 2 diabetes that works by reducing the liver's glucose produc...Everyday HealthDoes high-dose metformin cause lactic acidosis in type 2 diabetic patients after CABG surgery? A double blind randomized clinical trialMetformin reduces gluconeogenesis and glycogenolysis, and increases sensitivity of insulin receptors through multiple mechanisms. In addition, it reduces the le...National Institutes of Health (NIH) | (.gov) This is for informational purposes only. For medical advice or a diagnosis, consult a professional. AI responses may include mistakes. Learn more '

Uutta oli tämä: https://www.afar.org/tame-trial

Merformiinia siis kokeillaan myös terveillä.